[1] 范建高,贾继东. 脂肪性肝病诊疗进展[M]. 北京:人民卫生出版社,2009:79-87. [2] FAN JG,FARRELL GC. Epidemiology of non-alcoholic fatty liver disease in China[J]. J Hepatol,2009,50(1):204-210. [3] VUPPALANCHI R,CHALASANI N. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis:selected practical issues in their evaluation and management[J]. Hepatology,2009,49(2):306-317. [4] 王炳元,范建高. 第3届全国脂肪性肝病学术会议暨两岸三地高峰论坛纪要[J]. 实用肝脏病杂志,2009,12(6):402-403. [5] 范建高. 重视慢性病毒性肝炎合并脂肪肝的诊断与治疗[J]. 中华肝脏病杂志,2009,17(11):801-803. [6] 段晓燕,范建高. 代谢性危险因素与病毒性肝炎[J]. 实用肝脏病杂志,2009,12(6):462-467. [7] ALI R,CUSI K. New diagnostic and treatment approaches in non-alcoholic fatty liver disease(NAFLD)[J]. Ann Med,2009,41(2):265-278. [8] 范建高. 糖尿病与肝病的关系及其诊治对策[J]. 中华糖尿病杂志,2009,1(4):244-247. [9] FAN JG,FARRELL GC. Prevention of hepatocellular carcinoma in non-viral related liver diseases[J]. J Gastroenterol Hepatol,2009,24(5):712-719. [10] LOOMBA R,SIRLIN CB,SCHWIMMER JB,et al. Advances in pediatric nonalcoholic fatty liver disease[J]. Hepatology,2009,50(4):1282-1293. [11] RILEY P,AL BAKIR M,O'DONOHUE J,et al. Prescribing statins to patients with nonalcoholic fatty liver disease:real cardiovascular benefits outweigh theoretical hepatotoxic risk[J]. Cardiovasc Ther,2009,27(2):216-220. |